atyr pharma inc
(LIFE:Consolidated Issue Listed on NASDAQ Global Select )
Keith James Ph.D.
Member of Therapeutic Advisory Board, aTyr Pharma Inc.
|Age||Total Calculated Compensation||This person is connected to 23 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Dr. Keith James, Ph.D serves as Vice President and Visiting Investigator at The Scripps Research Institute in La Jolla. Previously, Dr. James was in a variety of executive research positions at Pfizer, including Vice President, Discovery research and Research site head of Pfizer La Jolla. He was responsible for research leading to the discovery of Relpax for migraine and Selzentry for HIV. Dr. James has been a Member of Therapeutic Advisory Board at aTyr Pharma Inc. ...
3545 John Hopkins CourtPhone: 858-731-8389
San Diego, California 92121
Board Members Memberships*There is no Board Members Memberships data available.
University of Cambridge
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|